“…The data on CBM types variety allow to create new constructs of mono/bi/multi-CBM-containing enzyme molecules/assemblies (enzylectins, postbiotics as enzymes [enzypostbiotics], "enzymes as receptors" [82] or enzycommunicators). They will be useful for probiotic, postbiotic, prebiotic, symbiotic and synbiotic co-functioning systems in organism, organ, tissue, cellular models and bioreactors of industrial, diagnostic and prognostic significance [43], [47], [48], [52], [68], [70]. Another promising possibility may be using probiotic microbial lectins [46]- [48].…”